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Background
MRI has generally been contraindicated in patients (pts)
with pacemakers (PM) or defibrillators (ICD) due to
concern of a variety of potential complications. Several
recent series have suggested potential safety of MRI in
pts with cardiac devices, but most excluded cardiac or
thoracic imaging. Additionally there is very limited data
on safety of CMR in pts with devices, especially in pts
with ICD.
Methods
Pts with devices underwent CMR on a 1.5-T Siemens
Avanto scanner utilizing a pre-specified protocol that
involved device interrogation and programming prior to,
and immediately after CMR to assess lead impedance,
battery voltage, and pacing capture/sensing thresholds.
Devices in PM dependent pts (intrinsic HR < 60 bpm)
were reprogrammed to asynchronous pacing mode,
whereas devices in non-PM dependent pts were repro-
grammed to pacing function deactivated. All underwent
rhythm, pulse oximetry, and visual monitoring during
CMR. All pts were scheduled for follow up device inter-
rogation to evaluate for later changes in device para-
meters. For hospitalized pts troponin levels were
measured prior to and 8 hours after CMR.
Results
Seventy nine CMR exams were performed in 64 pts [26
men, age 64.7±14.2 years, 34 with PM, and 30 with
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ICD] were on inpatients who had troponin levels drawn
before and after CMR. All pts underwent CMR without
complications, specifically none complained of heating,
and there were no malignant arrhythmias or device mal-
functions noted. Follow up device interrogation was per-
formed after 68 (86%) of the exams at 13.2 ± 20.8 days
after CMR. No device complications were noted during
the follow up period. Table 1 and Table 2 summarize
the changes in device parameters. We detected no sig-
nificant rise in troponin levels with CMR (0.046 ± 0.200
and 0.037 ± 0.132, p = 0.596 for pts with PM; and value
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Figure 1 Device parameters for PM and ICD measures before and
immediately after CMR.
Figure 2 Device parameters for PM and ICD measures at follow up
compared with the pre-test values.
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ICD).
Conclusions
Patients with PM or ICD may safely undergo CMR
using a pre-designed protocol without any clinically
meaningful change in device function.
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